RVTY Competitors & Alternatives
Compare Revvity Inc. with similar stocks in the same industry
Diagnostics & Research
RVTY
Main Stock$111.11
Tradestie Score
58
Market Cap
$10.65B
P/E Ratio
54.0
Revenue Growth
0.1%
Analyst Upside
+3.3%
Top Competitors
38 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
WAT
Waters Corp
|
$373.22
|
$19.04B | 47.8 | 58 | Compare |
|
ILMN
Illumina Inc
|
$190.05
|
$15.72B | 34.6 | 60 | Compare |
|
MEDP
Medpace Holdings, Inc. Common Stock
|
$530.19
|
$15.28B | 33.9 | 61 | Compare |
|
ICLR
Icon Plc
|
$166.10
|
$14.96B | 74.2 | 51 | Compare |
|
EG
Everest Group, Ltd.
|
$377.89
|
$14.83B | 7.5 | 60 | Compare |
|
BALL
Ball Corporation
|
$61.30
|
$13.74B | 18.0 | 58 | Compare |
|
EXAS
Exact Sciences Corp
|
$104.91
|
$10.68B | - | 65 | Compare |
|
QGEN
QIAGEN N.V.
|
$41.44
|
$10.04B | 21.2 | 61 | Compare |
|
CRL
Charles River Laboratories International, Inc.
|
$229.75
|
$8.39B | - | 59 | Compare |
|
GH
Guardant Health, Inc. Common Stock
|
$158.40
|
$7.81B | - | 60 | Compare |
More RVTY Analysis
Data updated: Jul 13, 2026 | Industry: Diagnostics & Research (SIC 3826)
38 stocks in this industry